drugset / Trial / NCT03027128
QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether haNK™ for Infusion is safe and effective in the treatment of metastatic or locally advanced solid tumors.
Timeline
- Start
- 2017-08-02
- Primary completion
- 2019-05-06
- Completion
- 2019-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | haNK™ for Infusion | Cell therapy | 1e+09 cells | Intravenous |
| Subject | haNK™ for Infusion | Cell therapy | 2e+09 cells | Intravenous |
| Subject | haNK™ for Infusion | Cell therapy | 4e+09 cells | Intravenous |